Live Breaking News & Updates on Nutraceutical Development Program

Stay updated with breaking news from Nutraceutical development program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PAO Group, Inc.: PAOG Announces Opportunity To Expand CBD Pharmaceutical Research

PAO Group, Inc.: PAOG Announces Opportunity To Expand CBD Pharmaceutical Research
Sandusky, Ohio (Newsfile Corp. - April 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company s ongoing CBD Pharmaceutical Development Program.
Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled, METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.
Since the acquisition, PAOG engaged Veristat, a contract research organization (CRO), dedicated to the clinical advance of therapies and treatments through regulatory approval. PAOG reports Veristat is making substantial progress in validating and supplementing the underlying research behind RespRx. ....

United States , Kostenloser Wertpapierhandel , Jim Diprima , Alkame Holdings Inc , American Cannabis Holdings Inc , Research Funding , Group Inc , Nutraceutical Development Program , Development Program , Securities Exchange , Extracts Inc , Ohio Newsfile Corp , Vivo Histological Research Study , Chronic Obstructive Pulmonary Disorder , New Research Funding And , Interest In Cannabis Extraction , Patented Cannabis Extraction , Cannabis Extraction , Alkame Holdings , North American Cannabis Holdings , Looking Statements , Securities Act , Securities Exchange Act , ஒன்றுபட்டது மாநிலங்களில் , ஜிம் டிப்ரிமா , அமெரிக்கன் கஞ்சா ஹோல்டிங்ஸ் இன்க் ,

PAOG Announces Negotiations To Acquire Partnership Interest In Patented Cannabis Extraction Technology

PAOG Announces Negotiations To Acquire Partnership Interest In Patented Cannabis Extraction Technology
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Jim Diprima , Alkame Holdings Inc , American Cannabis Holdings Inc , Research Funding , Group Inc , Nutraceutical Development Program , Development Program , Securities Exchange , Extracts Inc , Vivo Histological Research Study , Chronic Obstructive Pulmonary Disorder , New Research Funding And , Interest In Cannabis Extraction , Patented Cannabis Extraction , Cannabis Extraction , Alkame Holdings , North American Cannabis Holdings , Looking Statements , Securities Act , Securities Exchange Act , ஒன்றுபட்டது மாநிலங்களில் , ஜிம் டிப்ரிமா , அமெரிக்கன் கஞ்சா ஹோல்டிங்ஸ் இன்க் , ஆராய்ச்சி நிதி , குழு இன்க் ,

PAOG Announces Negotiations To Acquire Partnership Interest In Patented Cannabis Extraction Technology

PAOG Announces Negotiations To Acquire Partnership Interest In Patented Cannabis Extraction Technology
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Jim Diprima , Alkame Holdings Inc , American Cannabis Holdings Inc , Research Funding , Group Inc , Nutraceutical Development Program , Development Program , Securities Exchange , Extracts Inc , Vivo Histological Research Study , Chronic Obstructive Pulmonary Disorder , New Research Funding And , Interest In Cannabis Extraction , Patented Cannabis Extraction , Cannabis Extraction , Alkame Holdings , North American Cannabis Holdings , Looking Statements , Securities Act , Securities Exchange Act , ஒன்றுபட்டது மாநிலங்களில் , ஜிம் டிப்ரிமா , அமெரிக்கன் கஞ்சா ஹோல்டிங்ஸ் இன்க் , ஆராய்ச்சி நிதி , குழு இன்க் ,

PAOG To Publish Latest CBD Pharmaceutical Developments Tomorrow, Tuesday April 13, 2021

PAOG To Publish Latest CBD Pharmaceutical Developments Tomorrow, Tuesday April 13, 2021
News provided by
Share this article
Share this article
SANDUSKY, Ohio, April 12, 2021 /PRNewswire/ PAO Group, Inc. (USOTC: PAOG) today confirmed a management update on the company s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021.
Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT. ....

United States , Jim Diprima , Nutraceutical Development Program , Alkame Holdings Inc , Development Program , American Cannabis Holdings Inc , Securities Exchange , Extracts Inc , Group Inc , Chronic Obstructive Pulmonary Disorder , Alkame Holdings , North American Cannabis Holdings , Looking Statements , Securities Act , Securities Exchange Act , Pao Group , ஒன்றுபட்டது மாநிலங்களில் , ஜிம் டிப்ரிமா , வளர்ச்சி ப்ரோக்ர்யாம் , அமெரிக்கன் கஞ்சா ஹோல்டிங்ஸ் இன்க் , பத்திரங்கள் பரிமாற்றம் , சாறுகள் இன்க் , குழு இன்க் , நாள்பட்ட தடைசெய்யும் நுரையீரல் கோளாறு , வடக்கு அமெரிக்கன் கஞ்சா ஹோல்டிங்ஸ் , பார்க்கிறது அறிக்கைகள் ,

PAO Group, Inc.: PAOG CBD Pharmaceutical Development Update Coming Tomorrow, Tuesday April 13, 2021

PAO Group, Inc.: PAOG CBD Pharmaceutical Development Update Coming Tomorrow, Tuesday April 13, 2021
Sandusky, Ohio (Newsfile Corp. - April 12, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a management update on the Company s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021.
Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT .
PAOG is working with Veristat, a contract research organization (CRO), dedicated to the clinical advance of therapies and treatments through regulatory approval. PAOG anticipates soon announcing new breakthroughs in its CBD RespRx pharmaceutical research. ....

United States , Kostenloser Wertpapierhandel , Jim Diprima , Alkame Holdings Inc , American Cannabis Holdings Inc , Group Inc , Nutraceutical Development Program , Development Program , Securities Exchange , Ohio Newsfile Corp , Extracts Inc , Chronic Obstructive Pulmonary Disorder , Alkame Holdings , North American Cannabis Holdings , Looking Statements , Securities Act , Securities Exchange Act , ஒன்றுபட்டது மாநிலங்களில் , ஜிம் டிப்ரிமா , அமெரிக்கன் கஞ்சா ஹோல்டிங்ஸ் இன்க் , குழு இன்க் , வளர்ச்சி ப்ரோக்ர்யாம் , பத்திரங்கள் பரிமாற்றம் , சாறுகள் இன்க் , நாள்பட்ட தடைசெய்யும் நுரையீரல் கோளாறு , வடக்கு அமெரிக்கன் கஞ்சா ஹோல்டிங்ஸ் ,